law allows individual patients to apply for access to experimental treatments
outside of a drug trial if they have a serious or life-threatening disease or
condition; have no other treatment options left; and can persuade a qualified
physician to deliver the treatment. Under these circumstances, the FDA may, at
the agency’s discretion, grant “compassionate use” of the new medication. But
the program is marred by a prohibitively cumbersome application and
documentation process, and the agency refuses access rather arbitrarily. It can
even revoke permission after it has been granted.
Many states have already passed so-called
“Right-to-Try” laws, and
many more states are considering similar legislation.
Write to your senators and urge them to support the federal Right-to-Try law, S.2912.
Please Support S.2912
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]